Hyderabad-based SCIINV Biosciences has identified a new AI-driven repurposed antibiotic now entering human clinical trials. The breakthrough, backed by Whale Tank Biocatalyst, reduces development time and offers hope in combating antimicrobial resistance amid a stagnating global antibiotic pipeline.